PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients

Detalles Bibliográficos
Autores principales: Petrić, Daniela, Rački, Valentino, Graovac, Mirjana, Kaštelan, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616351/
http://dx.doi.org/10.1093/ijnp/pyw041.416
_version_ 1783266761587556352
author Petrić, Daniela
Rački, Valentino
Graovac, Mirjana
Kaštelan, Ana
author_facet Petrić, Daniela
Rački, Valentino
Graovac, Mirjana
Kaštelan, Ana
author_sort Petrić, Daniela
collection PubMed
description
format Online
Article
Text
id pubmed-5616351
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56163512017-11-27 PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients Petrić, Daniela Rački, Valentino Graovac, Mirjana Kaštelan, Ana Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616351/ http://dx.doi.org/10.1093/ijnp/pyw041.416 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Petrić, Daniela
Rački, Valentino
Graovac, Mirjana
Kaštelan, Ana
PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients
title PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients
title_full PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients
title_fullStr PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients
title_full_unstemmed PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients
title_short PM416. Efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients
title_sort pm416. efficacy and tolerability of paliperidone palmitate long-acting injectable antipsychotic: off-label use in first-episode adolescent schizophrenic patients
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616351/
http://dx.doi.org/10.1093/ijnp/pyw041.416
work_keys_str_mv AT petricdaniela pm416efficacyandtolerabilityofpaliperidonepalmitatelongactinginjectableantipsychoticofflabeluseinfirstepisodeadolescentschizophrenicpatients
AT rackivalentino pm416efficacyandtolerabilityofpaliperidonepalmitatelongactinginjectableantipsychoticofflabeluseinfirstepisodeadolescentschizophrenicpatients
AT graovacmirjana pm416efficacyandtolerabilityofpaliperidonepalmitatelongactinginjectableantipsychoticofflabeluseinfirstepisodeadolescentschizophrenicpatients
AT kastelanana pm416efficacyandtolerabilityofpaliperidonepalmitatelongactinginjectableantipsychoticofflabeluseinfirstepisodeadolescentschizophrenicpatients

Ejemplares similares